Protocol full text hidden due to copyright restrictions
Open the protocol to access the free full text link
Constraints in the FREE, MACRO and ADEQ scenarios
Women | Men | FREE | MACRO | ADEQ | Reference | |
---|---|---|---|---|---|---|
Nutritional constraints | ||||||
Proteins (% of total energy) | 10–20 | – | applied | applied | ( | |
Carbohydrates (% of total energy) | 50–75 | – | applied | applied | ( | |
Fats (% of total energy) | 20–35 | – | applied | applied | ( | |
Linolenic acid (% of total energy) | >0·5 | – | – | applied | ( | |
Linoleic acid (% of total energy) | 2·5–9·0 | – | – | applied | ( | |
EPA+DHA (g/d) | >0·25 | – | – | applied | ( | |
PUFA (% of total energy) | 6–11 | – | – | applied | ( | |
SFA (% of total energy) | <10 | – | – | applied | ( | |
Cholesterol (mg/d) | <300 | – | – | applied | ( | |
Free sugars (% of total energy) | <10 | – | – | applied | ( | |
Na (mg/d) | 1500–2365 | 1500–2759 | – | – | applied | ( |
Fibre (g/d) | >30 | >30 | – | – | applied | ( |
Ca (mg/d) | ≥900 | ≥900 | – | – | applied | ( |
Cu (mg/d) | ≥1·5 | ≥2 | – | – | applied | ( |
Fe (mg/d) | ≥16 | ≥9 | – | – | applied | ( |
Iodine (mg/d) | ≥150 | ≥150 | – | – | applied | ( |
Mg (mg/d) | ≥360 | ≥420 | – | – | applied | ( |
P (mg/d) | ≥750 | ≥750 | – | – | applied | ( |
K (mg/d) | ≥3100 | ≥3100 | – | – | applied | ( |
Se (µg/d) | ≥50 | ≥60 | – | – | applied | ( |
Vitamin A (µg/d) | 600–1600 | 800–1800 | – | – | applied | ( |
Thiamin (mg/d) | ≥1·1 | ≥1·3 | – | – | applied | ( |
Riboflavin (mg/d) | ≥1·5 | ≥1·6 | – | – | applied | ( |
Niacin (mg/d) | ≥11 | ≥14 | – | – | applied | ( |
Vitamin B12 (µg/d) | ≥2·4 | ≥2·4 | – | – | applied | ( |
Pantothenic acid (mg/d) | ≥5 | ≥5 | – | – | applied | ( |
Vitamin B6 (mg/d) | ≥1·5 | ≥1·8 | – | – | applied | ( |
Folic acid (µg/d) | ≥300 | ≥330 | – | – | applied | ( |
Vitamin C (mg/d) | ≥110 | ≥110 | – | – | applied | ( |
Vitamin D (µg/d) | ≥5 | ≥5 | – | – | applied | ( |
Vitamin E (mg/d) | ≥12 | ≥12 | – | – | applied | ( |
Zn (mg/d) | ≥10 | ≥12 | – | – | applied | ( |
Total energy (kcal/d) | Equal to the total energy of the mean observed diet | applied | applied | applied | ||
Cultural acceptability constraints | ||||||
Total weight | 80–120 % of total weight of the mean observed diet | applied | applied | applied | ||
Foods, food groups and subgroups | <90th percentile, calculated on the mean observed diet | applied | applied | applied | ||
Environmental constraints | ||||||
Total dietary GHGE | Incremental reduction (10 %) from level in the observed diet | applied | applied | applied |
FREE; no nutritional constraints; MACRO, constraints on macronutrients only; ADEQ, constraints on all nutrients; GHGE, greenhouse gas emissions.
8109 kJ/d (1938 kcal/d) for women, 10 891 kJ/d (2603 kcal/d) for men.
Calculated for men and women separately.
For foods, non-consumers excluded; for food subgroups and groups, non-consumers included.
Example 22
Permethrin and linolenic acid were tested for efficacy against 4- to 6-day old adult Aedes aegypti. For the following concentrations 3% linolenic acid, 0.0004 μg/mosquito of permethrin, and 0.0004 μg/mosquito of permethrin with 3% linolenic acid, at 1 hour we obtained 7%, 93%, and 77% knockdown respectively. At 24 hours we obtained 60%, 70%, and 63% mortality respectively. The CO2 control had 0% knockdown at 1 hour, and 0% mortality at 24 hours. The acetone standard had 3% knockdown at 1 hour, and 7% mortality at 24 hours. Results are shown in Table 13.
Example 6
Linolenic acid at concentrations of 1%, 5%, 10%, and 20% was tested for efficacy against 4- to 6-day old adult Aedes aegypti. At 1 hour we obtained 0%, 27%, 40%, and 93% knockdown, respectively. At 24 hours we obtained 3%, 33%, 83%, and 93% mortality, respectively. The CO2 control had 0% knockdown at 1 hour, and 7% mortality at 24 hours. The acetone standard had 0% knockdown at 1 hour, and 0% mortality at 24 hours. These data suggest that relatively high rates of linolenic acid exposure by contact, leads to mosquito mortality.
Example 33
We tested etofenprox+linolenic acid for efficacy against 3- to 5-day old adult Aedes aegypti. For the following concentrations 3% linolenic acid, 0.002 μg/mosquito of etofenprox, and 0.002 μg/mosquito of etofenprox with 3% linolenic acid, at 1 hour we obtained 0%, 83%, and 0% knockdown respectively. At 24 hours we obtained 3%, 53%, and 7% mean mortality respectively. The CO2 control and acetone standard both had 0% knockdown at 1 hour, and 0% mean mortality at 24 hours. Results are shown in Table 23.
Example 27
We tested pyrethrin+linolenic acid for efficacy against 4- to 6-day old adult Aedes aegypti. For the following concentrations 3% linolenic acid, 0.002 μg/mosquito of pyrethrin, and 0.002 μg/mosquito of pyrethrin with 3% linolenic acid, at 1 hour we obtained 17%, 90%, and 50% knockdown respectively. At 24 hours we obtained 7%, 57%, and 37% mean mortality respectively. The CO2 control and acetone standard both had 0% knockdown at 1 hour, and 0% mean mortality at 24 hours. Results are shown in Table 17.
Example 1
Variety 18GG0453L has shown uniformity and stability for all traits, as described in the following variety description information. The variety has been increased with continued observation for uniformity.
Table 1 provides data on morphological, agronomic, and quality traits for 18GG0453L. When preparing the detailed phenotypic information, plants of the new 18GG0453L variety were observed while being grown using conventional agronomic practices.